Radiopharm TheranosticsRADX
13F holders, Q4 2024 (December 31)4holders
$4.45avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Radiopharm Theranostics Ltd. (RADX) in their 13F filings. The largest holders were Silverarc Capital Management, LLC ($841K), Affinity Asset Advisors, LLC ($684K) and Regal Partners Ltd ($408K).
- Company
- Radiopharm Theranostics Ltd.
- CUSIP
- 75041J101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.9M |
| Exits | 0 | $0 |
Ownership 4 holders
| Silverarc Capital Management, LLC | 0.19% | New | 187,406 | $841K |
| Affinity Asset Advisors, LLC | 0.12% | New | 156,171 | $684K |
| Regal Partners Ltd | 0.04% | New | 90,909 | $408K |
| UBS Group AG | 0.00% | New | 1,317 | $6K |
"% of holder's portfolio" is RADX's weight in each manager's 13F, not the share of Radiopharm Theranostics Ltd. the manager owns.